Introduction
Evaluation of the process of care of patients with epilepsy, including audit, intervention and re-audit, is recommended in government-sponsored reports and national guidelines. [1] [2] [3] The TIGER study, 4 compared the process of care for, and the quality of life of, 1133 patients in 68 practices, after randomisation to control, intermediate, or intensive intervention groups. The control practices received a nationally developed clinical guideline 5 by post only. Intermediate intervention involved receipt of the guideline by post supported by interactive workshops and structured protocol documents, while intensive intervention practices received intermediate intervention plus a nurse specialist who supported and educated practices in the establishment of epilepsy review clinics.
The primary outcome was the SF-36 6 and the secondary outcome was a battery of pre-validated epilepsy specific, quality of life instruments [7] [8] [9] [10] [11] . None of the interventions were associated with improvements in patient's perception of quality of life or any measures of process of care. These included; uptake of the nurse-led intervention, an improvement in the number of review consultations or counselling sessions for epilepsy, and the quality of documentation of the consultations.
We have previously reported results of a comprehensive audit of care of patients with epilepsy living in Chester. 12 This article describes the results of a 2 year re-audit, discusses reasons for the observed changes, notably the coincidental acceptance of the New GP Contract, 13 limitations of this data and implications for co-ordination of care across the primary-secondary care interface.
Methods
First audit 12 The practice paper and computer records, of 610 patients of all ages with a diagnosis of epilepsy who were receiving repeat prescriptions for anti-epileptic drugs were reviewed. This took place from December 2001 to March 2003.
Intervention
An audit template for each patient was constructed. This included basic demographics, details of diagnosis, by whom, with attention directed to correspondence supporting an impression of an uncertain diagnosis, investigations, current seizure control (whether or not in remission) and review pattern. This concluded with individual categorisation and recommendations as follows; patient needs GP review, consider specialist referral, for three reasons; in remission consider drug withdrawal, diagnostic doubt and poor seizure control. Attention was also drawn to those patients whose compliance was in doubt and to women of childbearing age.
This was supplemented by a 2-h tutorial (85% attendance of local GPs) in which Dr. Smith gave an overview of the diagnosis and management of epilepsy. Dr. Minshall reported back on the audit findings for the practice concerned, on a named patient basis.
The educational intervention was completed in all practices after their individual audit was complete and the template completed, the first session was in 
Re-audit
Each practice was re-visited 2 years after the initial audit, practices 1-5 were re-audited from December 2003 to April 2004, practice 6-13 from July 2004 to March 2005. If a referral, or intervention, was made in the first consultation for epilepsy after the audit, and it related to an issue highlighted by the audit, it was assumed to be due to the audit and recorded accordingly. Outcomes relating to later practice interventions, or in patients already under shared care were documented separately.
Statistics were analysed using Graphpad computer software, using x 2 , proportional x 2 analysis, and with the re-audit Wilcoxon matched-pairs signedranks test.
Results

First audit
A summary of the findings from the first audit is shown in Table 1 .
Re-audit
There were three groups who did not complete the audit cycle and, therefore, were not included in review statistics.
There had been 42 deaths, none attributable to epilepsy. Fourteen had been reviewed in the first year, one in the second and there had been three referrals.
Twenty patients were no longer on therapy having had it stopped under medical supervision, 19 under hospital care, and 1 by the GP. There was no documented recurrence of seizures in this group, all followed up to at least 6 months.
Nineteen had stopped therapy themselves with no medical supervision. Twelve of these patients had been reviewed in the post audit period. Eighteen had a firm diagnosis, 13 had been non-compliant in the first audit. All had stopped 6 months before the end of the audit. Three had had a recurrence of seizures, one was unknown. One woman had stopped medication while pregnant to restart it postpartum, with no seizures. There had been two referrals in this group.
Fifty-two patients had left their practice, eight had been reviewed in the first year, two in the second, and four had been referred.
Therefore, a total of 477 patients were still on medication and completed the audit. Table 2 illustrates the change in overall review rate between the practices.
Individual changes between practices are shown in Fig. 1 The impact of a citywide audit with educational intervention This observation is supported by the change in the use of templates over the two years, the audit template was used by the practices 1-5, 84 times, and only 14 times in practices 6-13, but the latter group had clearly moved on to those designed for the New Contract, using those templates 173 times, compared to zero usage in practices 1-5.
One hundred and one were receiving shared care, 293 had seen their GP in the last year, 74 had been seen both at the hospital and by the GP. Therefore, 33% (157/477) had not seen any doctor at all in the previous year. This had improved from the original audit level of 51% ( p < 0.0001). One hundred and sixty six (35%) were being seen regularly (at least yearly) by their GP, compared with 16% in the first audit, ( p < 0.0001).
There were 141 (30%) patients with documented 'poor control', of these 65 (45%) were not under shared care, which equates to the estimate in the first audit.
The figures have not significantly changed but of course the shared care rate had not changed significantly either (see below).
Other measures from the re-audit are summarised in Table 4 , showing there was no overall change in the number of patients under shared care, compliance or hospital admissions.
There was a significant increase in documented remission and a significant decrease in A&E attendance.
The change in documentation of remission is illustrated in Fig. 2 . Documentation of control was much better in the latter stages of the audit once the New Contract was being implemented at 43%, but 1 year after the New Contract, the PCT figures bring this up to 63% overall across the city. However, even after this further increase in review rates, there has been no change in the proportion of patients with poor seizure control receiving shared care.
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I. Minshall, D. Smith There were 77 referrals made which related to issues highlighted in the audit, all of the original 610 patients were included in this section. Sixty-six of these patients attended outpatients. The outcomes of those referrals are illustrated in Table 5 , those highlighted in bold were positive outcomes.
There were 32 interventions in practice related to the audit, illustrated in Table 6 .
Of the 98 interventions related to the audit, 62 can be said to have had a positive impact on the care of the patient.
Discussion
This comprehensive, citywide audit of the process of care of patients with epilepsy reveals increases in patient review rates and proportion of patients in documented remission. However, neither of these measures approach the standards set by the New GP Contract.
Furthermore, although there were tangible benefits in some individuals we found little evidence of improved seizure control, except perhaps the significant fall in A&E attendance. It is disappointing that the proportion of patients with poor seizure control who were not receiving shared care remained unacceptably high especially when the value of specialist review is well recognised. 15 
What changes occurred?
The overall annual review rate increased from 41 to 63%, and then 1 year after the contract to 92%. Two practices exceeded contract standard of 90% while six others saw more than 80% and one reviewed 65%. Prior to the audit four practices were below the minimum standard of 25%. While two of these improved dramatically, the other two had not changed. Why did change in review rates occur?
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Although there was a significant improvement in review rate across the city in the first year postintervention, there was a much more impressive change in the following year, especially in practices 6-13 who were Contract influenced. The review rate in practices one to five fell off in the second year. This supports the cynical viewpoint of Davis et al. 4 that 'primary care practitioners do not see epilepsy care as their responsibility, and therefore see no need to prioritise its care. If this be the case, increased funding alone 16 will not be enough to improve the quality of patient care'. Increased funding, in terms of The Contract certainly had a dramatic impact on review rate, but it remains to be seen as to the quality which accompanies this change.
Review rates were higher--So what?
On one level it is useful to know what is happening as this permits comparison with other audit/research and recommended standards of care.
For example, we suspected that the initial remission rate of 29% was an artefact of poor documentation. 12 The rise to 43% and then 63% coincident with the improved review rate supports that argument. However, with the exception of one practice those practices with greater than 80% review rates report remission rates between 41 and 63% i.e. all below the contract standard of 70%.
There are two possible explanations. Firstly, the contract standard may be set too high. CSAG, 1 which sampled 1652 patients using postal questionnaires, reported a remission rate of only 52%. Alternatively there may be many patients in the community who are sub-optimally diagnosed and treated. Two studies, 17,15 conducted 10 years apart, report that patients with refractory epilepsy rendered seizure-free by treatment change to be 12/80 (15%) and 17/55 (31%), respectively. Therefore, that the proportion of patients with uncontrolled seizures not under shared care remained as high as 46% is a matter of concern.
Patients stopping treatment themselves
Nineteen patients had stopped medication by themselves, plus one pregnant woman who subsequently restarted. A study in both primary and secondary care settings 18 concurs in observing that many patients are uncertain about the necessity for long-term therapy. This, in turn, may contribute to poor or erratic compliance, which is a risk factor for epilepsy-related sudden death. 19 By highlighting these issues to GPs this project has gone some way to tackle these serious problems. Patients in remission merit at least one thorough discussion of the need for long-term therapy. Ignorant of the risks of abrupt withdrawal 20 and the driving regulations 21 patients will often experiment without discussion, and stop medication of their own accord. 22 For patients who drive the evidence indicates that they feel compelled to stay on treatment indefinitely 23 and, therefore, this discussion can take place in the GP surgery, n = 16 in this study.
Compliance
Monitoring compliance is an important role for the GP, exploring the patient's perspective and can be crucial to the management of non-compliance, they often see taking medication as stigmatising. 24 Referral for more information about stopping medication may be helpful. 25 A study of admission to a district general hospital, 26 suggested that most admissions were due to potentially mutable problems including poor compliance rather than difficult epilepsy per se. The non-compliance rate, similar to other primary care audits, 27 did fall by 2% but this was not significant, but there was a significant fall in A&E attendance. The initial audit highlighted all those patients who were non-complaint, at the educational session and on the template. Despite this prompt, and there were 84 noncompliant patients in the first audit, discussion of the issue are documented in only three patients, one of whom was referred.
How clinically effective is the New Contract?
The New Contract had a clear benefit in review rates and seizure documentation. But the only clinical requirement is to 'review medication', this is from a population of clinicians who accept themselves, 28 and appear to patients, 29 as having a poor knowledge of epilepsy. There is a potential to miss important factors in the care of patients with epilepsy, this audit avoids this by reviewing and summarising the cases. For example, the patient with a misdiagnosis on treatment, who appears 'controlled'; the failure to recognise minor seizures in someone who is driving; and the woman of child bearing age on valproate with a controlled partial epilepsy who could be on a less teratogenic drug; asking about side effects; and reminding GPs, that if at all possible, patients with poor control should be under review by a specialist. The dramatic improvement in review rate was not mirrored by an equivalent rise in shared care, the level of which fell slightly. Forty five percent of patients with documented poor control are not under shared care despite the education, template and New Contract.
The first year of the New Contract was a busy, with many targets to reach, some more financially lucrative than epilepsy, which carries only a small number of 'points'. The New Contract has at least encouraged review, maybe with time, now the first year of box ticking is over, then some of the more challenging issues can be addressed. But other chronic diseases are being added to the QOF such as renal disease and mental health, so any time for genuine reflection is diluted. Chester was in a much stronger position having all its patients with epilepsy already audited with an accurate register, old notes reviewed and summarised, plus the GPs having had some education (85% compared with only 9.8% of all primary care staff in the TIGER trial). The fall off in review rate in the group affected mainly by the educational process in the second year, implies that education and encouragement needs to be ongoing and yearly to sustain the improvement in care.
This project perhaps adds to the argument that PCTs need to train and employ GPs with special interest in epilepsy and epilepsy nurse specialists. There is a huge workload of un-addressed issues to be attended to. GPs have a reputation for poor levels of knowledge of epilepsy and the ability to give the information that patients require. A well trained, intermediate team can fill the gap between primary and secondary care, allowing quick efficient referrals, with hopefully, quality outcomes.
Implications for clinical practice and future research
There should be an ongoing educational program in each PCT on the management of epilepsy. PCTs should consider training interested GPs to become GPwSI in epilepsy, and nursing staff to become epilepsy nurse specialists.
The indicators in the New Contract need some refinement, to allow prompts for patients' unmet needs, such as all patients with uncontrolled epilepsy should be ideally under the care of a specialist, have side effects been discussed, is the diagnosis correct, and has this woman of childbearing age been properly counselled?
The audit needs to be repeated on the same group of patients, with the New Contract having been in place for 3 years, to assess the true effect of that change.
Conclusion
A citywide audit and educational session, highlighting issues relevant to each individual patient, improved the overall review rate of patients with epilepsy across the city. Individual issues promoted referral, with positive outcomes, hence better quality care. There was recent Government change, which has had a dramatic effect on the review rate of patients with epilepsy and some aspects of documentation. But the relatively simplistic clinical requirements of the New Contract potentially might not meet the true needs of this patient group. The number of patients with documented poor control not under shared care is still unacceptably high. PCTs need to review their service provision for epilepsy in order to meet the needs highlighted in this project.
